McKesson (MCK) Competitors $708.49 -6.05 (-0.85%) Closing price 03:58 PM EasternExtended Trading$708.50 +0.01 (+0.00%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MCK vs. HOLX, HQY, HSIC, MMSI, AMN, CRL, HUM, ITGR, WST, and CORShould you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Hologic (HOLX), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Charles River Laboratories International (CRL), Humana (HUM), Integer (ITGR), West Pharmaceutical Services (WST), and Cencora (COR). These companies are all part of the "medical" sector. McKesson vs. Its Competitors Hologic HealthEquity Henry Schein Merit Medical Systems AMN Healthcare Services Charles River Laboratories International Humana Integer West Pharmaceutical Services Cencora Hologic (NASDAQ:HOLX) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership. Do analysts rate HOLX or MCK? Hologic presently has a consensus price target of $78.75, indicating a potential upside of 19.83%. McKesson has a consensus price target of $706.83, indicating a potential downside of 0.23%. Given Hologic's higher probable upside, analysts plainly believe Hologic is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.47McKesson 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.86 Does the media favor HOLX or MCK? In the previous week, McKesson had 23 more articles in the media than Hologic. MarketBeat recorded 42 mentions for McKesson and 19 mentions for Hologic. McKesson's average media sentiment score of 1.05 beat Hologic's score of 0.98 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 7 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 28 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, HOLX or MCK? Hologic has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Which has stronger valuation & earnings, HOLX or MCK? McKesson has higher revenue and earnings than Hologic. McKesson is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.63$789.50M$2.3727.73McKesson$359.05B0.25$3.30B$25.8327.43 Is HOLX or MCK more profitable? Hologic has a net margin of 13.83% compared to McKesson's net margin of 0.92%. Hologic's return on equity of 19.71% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Hologic13.83% 19.71% 10.87% McKesson 0.92%-201.12%5.83% Do institutionals & insiders believe in HOLX or MCK? 94.7% of Hologic shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 1.9% of Hologic shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryHologic beats McKesson on 9 of the 16 factors compared between the two stocks. Get McKesson News Delivered to You Automatically Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCK vs. The Competition Export to ExcelMetricMcKessonMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$89.40B$15.78B$5.61B$20.79BDividend Yield0.40%1.43%5.24%3.71%P/E Ratio27.4318.6527.9627.89Price / Sales0.252.32430.8942.50Price / Cash18.3917.3837.4622.63Price / Book-52.403.788.044.57Net Income$3.30B$430.42M$3.18B$988.81M7 Day Performance-1.50%-1.34%3.72%0.21%1 Month Performance-1.15%1.62%3.72%3.91%1 Year Performance23.16%17.92%29.92%11.35% McKesson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCKMcKesson4.5346 of 5 stars$708.49-0.8%$706.83-0.2%+21.7%$89.40B$359.05B27.4345,000Positive NewsAnalyst ForecastHOLXHologic4.8352 of 5 stars$64.37-0.6%$77.42+20.3%-11.8%$14.34B$4.03B27.167,063Analyst ForecastHQYHealthEquity3.782 of 5 stars$101.83-0.3%$118.09+16.0%+23.0%$8.81B$1.20B74.333,120Positive NewsAnalyst ForecastInsider TradeHSICHenry Schein3.277 of 5 stars$73.45-1.6%$79.30+8.0%+16.1%$8.94B$12.67B22.9525,000Analyst ForecastMMSIMerit Medical Systems4.2301 of 5 stars$91.12-2.6%$109.11+19.7%+9.2%$5.39B$1.36B44.677,400Positive NewsAnalyst ForecastAMNAMN Healthcare Services4.3231 of 5 stars$21.23-3.1%$32.08+51.1%-53.1%$812.68M$2.98B-4.902,968CRLCharles River Laboratories International4.5497 of 5 stars$153.93-2.0%$171.85+11.6%-19.3%$7.56B$4.05B-236.8220,100Positive NewsAnalyst UpgradeHUMHumana4.537 of 5 stars$237.00-1.1%$280.76+18.5%-38.8%$28.60B$117.76B16.7665,680Positive NewsITGRInteger2.9421 of 5 stars$117.05-3.3%$145.00+23.9%+6.2%$4.08B$1.72B55.4711,000News CoverageWSTWest Pharmaceutical Services4.8417 of 5 stars$221.49-0.3%$320.00+44.5%-28.7%$15.91B$2.90B34.7710,600CORCencora4.5268 of 5 stars$302.43+2.1%$306.33+1.3%+33.7%$58.62B$293.96B35.0846,000Positive News Related Companies and Tools Related Companies HOLX Competitors HQY Competitors HSIC Competitors MMSI Competitors AMN Competitors CRL Competitors HUM Competitors ITGR Competitors WST Competitors COR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MCK) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding McKesson Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share McKesson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
